RTP News March 2026
20 March 2026
(Last updated: 20 Mar 2026 13:55)
New coalition will transform the lives of thousands with respiratory disease
An ambitious new national coalition will speed up diagnosis, improve treatment and transform the lives of thousands of people affected by asthma and lung disease.
The Respiratory Transformation Partnership (RTP) brings together health innovation networks alongside NHS systems, four major industry partners (AstraZeneca, Chiesi, GSK and Sanofi), the Office for Life Sciences, NHS England, professional bodies and the third sector to address unmet need and make better use of innovative treatments and technology.
It was launched by the Health Minister Dr Zubir Ahmed on 17 March. He said: “Too many people with asthma and lung disease end up rushed to hospital when, with the right care and support, that admission could have been avoided entirely.
“This £10 million partnership is a concrete example of what our reform agenda looks like in practice - shifting care out of hospitals and into communities, using data to reach patients who have been missed, and working hand-in-hand with industry to get the best treatments to the people who need them most.”
Health Innovation Oxford and Thames Valley (HIOTV) is leading the programme on behalf of the Health Innovation Network.
Professor Ben Bridgewater, Executive Chair of the Health Innovation Network, said: “Through the implementation of this innovative partnership working in local communities across the country patient outcomes will be improved, and national productivity gains can be made. This programme will create a practical blueprint of how innovation and collaboration can deliver better outcomes for patients while reducing pressure on hospitals and driving economic growth.”
Read more about the Respiratory Transformation Partnership at
https://www.healthinnovationoxford.org/clinical-priorities/respiratory/the-respiratory-transformation-partnership/?utm_source=newsletter&utm_medium=partner&utm_campaign=rtp
View other News